EDAP Reports First Quarter 2024 Financial Results
May 16, 2024 08:00 ET
|
EDAP TMS S.A.
Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023Q1 2024 total revenue...
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
May 13, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...
LogicMark, Inc. to Present at Virtual Emerging Growth Conference on May 8, 2024
May 07, 2024 18:03 ET
|
LogicMark, Inc.
LOUISVILLE, K.Y., May 07, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the...
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
May 06, 2024 08:00 ET
|
EDAP TMS S.A.
Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the HIFU-treated arm versus 86.2% in patients who...
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
May 02, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of expanded concepts from clinical notes -- including family history, medication details reported to...
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
May 02, 2024 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, May 16th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
April 30, 2024 04:00 ET
|
Alvotech
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S....
Recovering Patient Reunites with Penn Highlands DuBois Trauma Team Who Saved His Life
April 24, 2024 11:25 ET
|
Penn Highlands Healthcare
DuBois, Pennsylvania, April 24, 2024 (GLOBE NEWSWIRE) -- March 9, 2024 started out as just a normal day at work in the gas well industry for 47-year-old Timothy Richmond. However, his day turned out...
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
April 23, 2024 08:00 ET
|
EDAP TMS S.A.
LYON, France, April 23, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that final results from the HIFI Study, the largest clinical trial ever...
LogicMark, Inc. Reports Fourth Quarter and Full Year 2023 Results
April 18, 2024 09:00 ET
|
LogicMark, Inc.
LOUISVILLE, Ky., April 18, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the...